Belharra Therapeutics’ Multi-year Collaboration with Genentech

Fenwick represented Belharra Therapeutics on the deal. Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Dropbox’s Acquisition of FormSwift

Fenwick represented FormSwift on the deal. FormSwift, a cloud-based service that gives individuals and businesses a simple solution to create, complete, edit and save critical business...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BILL’s Acquisition of Finmark

Fenwick represented BILL on the deal. BILL (NYSE: BILL), a leader in financial automation software for small and midsize businesses (SMBs), announced its completed acquisition of Finmark,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Helbiz’s Acquisition of Wheels Labs

Fenwick represented Wheels Labs on the deal. Wheels Labs, a last-mile, shared electric mobility platform using proprietary vehicles with integrated helmet technology, announced its acquisition by Helbiz,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here